Access To Medicine Foundation
  • Who we are
  • What we do
  • Impact
  • Insights & resources
  • News & events
  • Donate
Donate

Who we are

An independent non-profit organisation accelerating progress toward global health equity.

  • About us
  • How we drive change
  • Our strategy 2022 - 2026
  • Governance
  • Team
  • Funders
  • Annual reports

What we do

We catalyse progress toward equitable access to essential medicines in low- and middle-income countries through our work across diverse research areas.

  • R&D-based pharma companies
  • Medical gas companies
  • Generic medicine manufacturers
  • Diagnostics companies
  • Vaccine manufacturers
  • Antimicrobial resistance
  • Diabetes care

Impact

Discover how our work drives real-world progress on access to medicine.

  • Our achievements
  • Voices of our community
  • How we drive change
  • Partner with us

Insights & resources

Discover our evidence-based research, insights and other changemaking tools.

  • Research hub
  • Company profiles & report cards
  • Access insights
  • The Health Equity podcast
  • Health Equity through Her Lens

News & events

Stay informed on our latest events, collaborations, engagements, and Foundation news.

  • News
  • Events & engagements
  • In the media

Follow us

Often searched

Index ranking

Vacancies

10 year analysis

Follow us

  • About us
  • How we drive change
  • Our strategy 2022 - 2026
  • Governance
  • Team
  • Funders
  • Annual reports
  • R&D-based pharma companies
  • Medical gas companies
  • Generic medicine manufacturers
  • Diagnostics companies
  • Vaccine manufacturers
  • Antimicrobial resistance
  • Diabetes care
  • Our achievements
  • Voices of our community
  • How we drive change
  • Partner with us
  • Research hub
  • Company profiles & report cards
  • Access insights
  • The Health Equity podcast
  • Health Equity through Her Lens
  • News
  • Events & engagements
  • In the media

Date

08 July 2020

Jayasree K. Iyer discusses COVID-19 and its impact on progress against HIV, TB and malaria

In this episode of Toronto-based Cited podcast, Access to Medicine Foundation Executive Director, Jayasree K. Iyer, joins the show to discuss how the COVID-19 pandemic has disrupted the existing global health landscape.

Direct links

Listen to the podcast

One of three guests invited to the episode, Jayasree K. Iyer joins the podcast 25 minutes in to discuss the impact that COVID-19 has already had on existing progress made on HIV, TB and malaria. In describing the consequences of the pandemic, she points to medicine and material supply chain disruptions, closing of borders, and an overarching shift of focus from existing health crises in low- and middle-income countries to treating patients of the novel coronavirus.

Elaborating on the ways the pandemic as already affected vulnerable communities, she says:

"In countries like South Africa, which has the world’s largest HIV epidemic and about 300,000 people live with tuberculosis right now, the fear of coronavirus has emptied out hospitals. While clinics remain open in the best of their capacity, the number of people that come in and get tested for TB has been dropping by half. HIV testing is down by a quarter since the national lockdown began on March 27th. ... The consequences are extremely catastrophic. All the things that we've done so far are really being threatened by what you see with COVID."

Access to Medicine Foundation

Subscribe to our newsletter

Vacancies FAQs Contact us

Follow us

Access to Medicine Foundation is funded by

Terms & conditions Privacy & cookie policy Disclaimer

Copyright 2004 - 2026 Access to Medicine Foundation - All Rights Reserved